Ann Emerg Med

1. DIMITROV K, Merkle F, Dimitrov M, Merkle S, et al
   Major Adverse Events With Chimeric Antigen Receptor T-Cell Therapy: Presentation, Diagnosis, and Resuscitation.
   Ann Emerg Med. 2026;87:229-238.
   

   >> Share

   
   

   
   J Public Health Manag Pract

2. VEST BM, Chambers MK, Thomas M, Arena S, et al
   Implementing Harm Reduction Vending Machines to Reduce Opioid Overdose Risk: Description of a Centralized Implementation Model, Pros, Cons, and Lessons Learned.
   J Public Health Manag Pract. 2026;32:237-244.
   

   >> Share

   
   
3. DIXON SL, Wilson J, Jacobs DE, Breysse J, et al
   Challenges of Importing Residential Lead Paint Inspection and Risk Assessment Reports Into a National Database.
   J Public Health Manag Pract. 2026;32:253-259.
   

   >> Share

   
   

   
   JAMA

4. ANDERER S
   Decline in US Overdose Deaths May Be Tied to Fentanyl Disruption.
   JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23028.
   

   >> Share

   
   

   
   Med J Aust

5. WONG A, McNulty R, Hodgson SE, Gunja N, et al
   Early Cessation of Acetylcysteine Treatment After Paracetamol Overdose (NACSTOP 2): A Non-Inferiority Randomised Controlled Trial.
   Med J Aust. 2026;224:e70114.
   

   >> Share

   
   

   
   PLoS One

6. ALHARBI KS, Afzal M, Alenezi SK, ALQahtani R, et al
   Oxyphenbutazone improves memory and learning impairments in LPS-induced neurotoxicity via modulating TGF-beta/NF-kappaB/IkappaB-alpha pathways: In silico and in vivo study.
   PLoS One. 2026;21:e0337611.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share